VMD - Viemed Healthcare: Long-Term Bull Remains Intact But Patience Required

2024-04-17 06:07:19 ET

Summary

• Viemed Healthcare's stock has returned close to 50% since a 'Buy' rating was issued over 27 months ago.
• Growth projections for Viemed are slowing, leading to bearish revisions in sales and earnings.
• The company's technology rollout and regulatory environment are still providing potential for future growth.

Intro

We originally stamped a ' Buy ' rating on Viemed Healthcare, Inc. ( VMD ) in December of 2021 when the stock's long-term trend turned bullish on strong underlying top-line sales growth. Shares were trading just north of $5.40 at the time, which means they have returned close to 50% since issuing that 'Buy' rating over 27 months ago....

For further details see: